CERTAIN INFORMATION, MARKED BY [***], HAS BEEN EXCLUDED BECAUSE IT BOTH (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.** EVALUATION AgreementEvaluation Agreement • January 25th, 2021 • Aptorum Group LTD • Pharmaceutical preparations • California
Contract Type FiledJanuary 25th, 2021 Company Industry JurisdictionThis Evaluation Agreement (“Agreement”) is between Illumina, Inc., having offices at [***] (“Illumina") and Aptorum Innovations Holding Limited, having offices at 4T.07, 17 Hanover Square, Mayfair, London, United Kingdom W1S 1BN (“AIHL”), and is effective as of the date of last signature below ("Effective Date"). Illumina and AIHL may be referred to individually as a “Party” or collectively as “Parties.”